A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics and personal judgments...
While Paxlovid remains a ‘life-saving drug,’ Mass General Brigham researchers found that patients experiencing virologic rebound after treatment may remain contagious A new study by investigators from Mass General...
The XBB.1.5 subvariant, known informally as “Kraken”, is the latest in a menagerie of Omicron subvariants to dominate the headlines, following increasing detection in the United States and United Kingdom. But there have...
Vaccine hesitancy about COVID-19 vaccines is a positive predictor of negative side effects with vaccination—an example of the “nocebo” effect—according to a study in Scientific Reports. Nocebo, a play on...
The COVID pandemic showed lack of preparedness in many public health areas all over Europe. One such gap – often overlooked – is the lack of tools to rapidly conduct clinical studies on new vaccines. This gap has...